Blogs

Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials

By Aesthetic Multispecialty Society posted Nov 23, 2020 05:34 AM

  
.
0 comments
0 views

Permalink